A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization
Navya Sree Kola Srinivas,1 Ruchi Verma,2 Girish Pai Kulyadi,1 Lalit Kumar1 1Department of Pharmaceutics, 2Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India Abstract: Gefitinib is an anticancer agent which acts by inhib...
Guardado en:
Autores principales: | Kola Srinivas NS, Verma R, Pai Kulyadi G, Kumar L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f33cc91ad291476b93ac0b71fab0d6f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics
por: Gunjan Jeswani, et al.
Publicado: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
por: Tonya N. Watkins, et al.
Publicado: (2018) -
A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies
por: Narayan R, et al.
Publicado: (2017) -
DETERMINACIÓN DE LAS CONDICIONES DE MICROENCAPSULACIÓN DE UN BACULOVIRUS ENTOMOPATÓGENO MEDIANTE COACERVACIÓN CON EUDRAGIT S100® DETERMINATION OF THE BASIC CONDITIONS FOR MICROENCAPSULATION OF AN ENTHOMOPATHOGENIC BACULOVIRUS BY MEANS OF COACERVATION USING EUDRAGIT S100®
por: Laura F VILLAMIZAR R, et al.
Publicado: (2008) -
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
por: Kate S, et al.
Publicado: (2019)